Keppra for Cervical Dystonia

• Status: Terminated
• Trial end date: 2007-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate if there is an improved response in CD symptoms when Keppra is used as adjunctive therapy to Botox.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of South Florida
• Treatments: Etiracetam; Levetiracetam

Criteria

Inclusion Criteria:

• Patients will have received their last Botox injections 12-16 weeks ago

• Any oral medications for cervical dystonia will be stable for 4 weeks and will continue throughout the study

Exclusion Criteria:

• Less than 21 years old

• Received Botox more than 16 weeks ago

• Not on a stable dose of oral medications for cervical dystonia